New Data Forecast More Oral PDE4 Inhibitors for Psoriasis admin March 24, 2023 Medical News A new oral phosphodiesterase-4 (PDE4) inhibitor achieved impressive rates of complete or near-complete skin clearance in a phase 2 study that also found the drug was well tolerated. Medscape Medical News Post navigation Previous Previous post: CT Results in Myositis Inform Cancer Screening Strategies